EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2

Por Gómez-Benito, M, Conchillo, A, García, M A, Vázquez, I, Maicas, M, Vicente, C, Cristobal, I, Marcotegui, N, García-Ortí, L, Bandrés, E, Calasanz, M J, Alonso, M M, Odero, M D
Publicado em 2010

Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression

Por Pellagatti, A, Roy, S, Di Genua, C, Burns, A, McGraw, K, Valletta, S, Larrayoz, M J, Fernandez-Mercado, M, Mason, J, Killick, S, Mecucci, C, Calasanz, M J, List, A, Schuh, A, Boultwood, J
Publicado no Leukemia (2016)

The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia

Por Rio-Machin, A, Gómez-López, G, Muñoz, J, Garcia-Martinez, F, Maiques-Diaz, A, Alvarez, S, Salgado, R N, Shrestha, M, Torres-Ruiz, R, Haferlach, C, Larráyoz, M J, Calasanz, M J, Fitzgibbon, J, Cigudosa, J C
Publicado no Leukemia (2017)

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes

Por McGraw, K L, Zhang, L M, Rollison, D E, Basiorka, A A, Fulp, W, Rawal, B, Jerez, A, Billingsley, D L, Lin, H-Y, Kurtin, S E, Yoder, S, Zhang, Y, Guinta, K, Mallo, M, Solé, F, Calasanz, M J, Cervera, J, Such, E, González, T, Nevill, T J, Haferlach, T, Smith, A E, Kulasekararaj, A, Mufti, G, Karsan, A, Maciejewski, J P, Sokol, L, Epling-Burnette, P K, Wei, S, List, A F
Publicado no Blood Cancer J (2015)